188 related articles for article (PubMed ID: 22170412)
21. Macroscopic small bowel mucosal injury caused by chronic nonsteroidal anti-inflammatory drugs (NSAID) use as assessed by capsule endoscopy.
Caunedo-Alvarez A; Gómez-Rodríguez BJ; Romero-Vázquez J; Argüelles-Arias F; Romero-Castro R; García-Montes JM; Pellicer-Bautista FJ; Herrerías-Gutiérrez JM
Rev Esp Enferm Dig; 2010 Feb; 102(2):80-5. PubMed ID: 20361843
[TBL] [Abstract][Full Text] [Related]
22. A randomized, double-blind, celecoxib- and placebo-controlled study of the effectiveness of CS-706 in acute postoperative dental pain.
Moberly JB; Xu J; Desjardins PJ; Daniels SE; Bandy DP; Lawson JE; Link AJ; Truitt KE
Clin Ther; 2007 Mar; 29(3):399-412. PubMed ID: 17577461
[TBL] [Abstract][Full Text] [Related]
23. COMPARISON OF PRE-EMPTIVE EFFECT OF MELOXICAM AND CELECOXCIB ON POST-OPERATIVE ANALGESIA: A DOUBLE-BLIND, RANDOMIZED CLINICAL TRIAL.
Aghadavoudi O; Saryazdi HH; Shafa A; Ramezani A
Middle East J Anaesthesiol; 2015 Oct; 23(3):289-94. PubMed ID: 26860018
[TBL] [Abstract][Full Text] [Related]
24. Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the Safety and Efficacy Large-scale Evaluation of COX-inhibiting Therapies (SELECT) trial in osteoarthritis.
Dequeker J; Hawkey C; Kahan A; Steinbrück K; Alegre C; Baumelou E; Bégaud B; Isomäki H; Littlejohn G; Mau J; Papazoglou S
Br J Rheumatol; 1998 Sep; 37(9):946-51. PubMed ID: 9783758
[TBL] [Abstract][Full Text] [Related]
25. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
[TBL] [Abstract][Full Text] [Related]
26. Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy.
Goldstein JL; Eisen GM; Lewis B; Gralnek IM; Aisenberg J; Bhadra P; Berger MF
Aliment Pharmacol Ther; 2007 May; 25(10):1211-22. PubMed ID: 17451567
[TBL] [Abstract][Full Text] [Related]
27. Cyclooxygenase inhibition: between the devil and the deep blue sea.
Hawkey CJ
Gut; 2002 May; 50 Suppl 3(Suppl 3):III25-30. PubMed ID: 11953329
[TBL] [Abstract][Full Text] [Related]
28. Acute gastrointestinal permeability responses to different non-steroidal anti-inflammatory drugs.
Smecuol E; Bai JC; Sugai E; Vazquez H; Niveloni S; Pedreira S; Mauriño E; Meddings J
Gut; 2001 Nov; 49(5):650-5. PubMed ID: 11600467
[TBL] [Abstract][Full Text] [Related]
29. Comparison of gastroduodenal ulcer incidence in healthy Japanese subjects taking celecoxib or loxoprofen evaluated by endoscopy: a placebo-controlled, double-blind 2-week study.
Sakamoto C; Kawai T; Nakamura S; Sugioka T; Tabira J
Aliment Pharmacol Ther; 2013 Feb; 37(3):346-54. PubMed ID: 23216412
[TBL] [Abstract][Full Text] [Related]
30. Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment.
Hawkey C; Kahan A; Steinbrück K; Alegre C; Baumelou E; Bégaud B; Dequeker J; Isomäki H; Littlejohn G; Mau J; Papazoglou S
Br J Rheumatol; 1998 Sep; 37(9):937-45. PubMed ID: 9783757
[TBL] [Abstract][Full Text] [Related]
31. Less small-bowel injury with lumiracoxib compared with naproxen plus omeprazole.
Hawkey CJ; Ell C; Simon B; Albert J; Keuchel M; McAlindon M; Fortun P; Schumann S; Bolten W; Shonde A; Hugot JL; Yu V; Arulmani U; Krammer G; Rebuli R; Toth E
Clin Gastroenterol Hepatol; 2008 May; 6(5):536-44. PubMed ID: 18242145
[TBL] [Abstract][Full Text] [Related]
32. Assessment of comparative pain relief and tolerability of SKI306X compared with celecoxib in patients with rheumatoid arthritis: a 6-week, multicenter, randomized, double-blind, double-dummy, phase III, noninferiority clinical trial.
Song YW; Lee EY; Koh EM; Cha HS; Yoo B; Lee CK; Baek HJ; Kim HA; Suh Y; Kang SW; Lee YJ; Jung HG
Clin Ther; 2007 May; 29(5):862-873. PubMed ID: 17697905
[TBL] [Abstract][Full Text] [Related]
33. Meloxicam: selective COX-2 inhibition in clinical practice.
Furst DE
Semin Arthritis Rheum; 1997 Jun; 26(6 Suppl 1):21-7. PubMed ID: 9219316
[TBL] [Abstract][Full Text] [Related]
34. Uterine relaxant effects of cyclooxygenase-2 inhibitors in vitro.
Slattery MM; Friel AM; Healy DG; Morrison JJ
Obstet Gynecol; 2001 Oct; 98(4):563-9. PubMed ID: 11576568
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of celecoxib, meloxicam and paracetamol in elderly Kashin-Beck disease (KBD) patients.
Luo R; Liu G; Liu W; Pei F; Zhou Z; Li J; Shen B; Kang P; Xie Q; Ma X
Int Orthop; 2011 Sep; 35(9):1409-14. PubMed ID: 20549501
[TBL] [Abstract][Full Text] [Related]
36. Incidence of gastroduodenal ulcers during treatment with celecoxib or diclofenac: pooled results from three 12-week trials in Chinese patients with osteoarthritis or rheumatoid arthritis.
Cheung R; Cheng TT; Dong Y; Lin HY; Lai K; Lau CS; Feng H; Parsons B
Int J Rheum Dis; 2010 May; 13(2):151-7. PubMed ID: 20536600
[TBL] [Abstract][Full Text] [Related]
37. Celecoxib plus aspirin versus naproxen and lansoprazole plus aspirin: a randomized, double-blind, endoscopic trial.
Goldstein JL; Cryer B; Amer F; Hunt B
Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1167-74. PubMed ID: 17916545
[TBL] [Abstract][Full Text] [Related]
38. The APC and PreSAP trials: a post hoc noninferiority analysis using a comprehensive new measure for gastrointestinal tract injury in 2 randomized, double-blind studies comparing celecoxib and placebo.
Arber N; Lieberman D; Wang TC; Zhang R; Sands GH; Bertagnolli MM; Hawk ET; Eagle C; Coindreau J; Zauber A; Lanas A; Levin B
Clin Ther; 2012 Mar; 34(3):569-79. PubMed ID: 22386831
[TBL] [Abstract][Full Text] [Related]
39. Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.
Chen YF; Jobanputra P; Barton P; Bryan S; Fry-Smith A; Harris G; Taylor RS
Health Technol Assess; 2008 Apr; 12(11):1-278, iii. PubMed ID: 18405470
[TBL] [Abstract][Full Text] [Related]
40. The effectiveness of a weak opioid medication versus a cyclo-oxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug in treating flare-up of chronic low-back pain: results from two randomized, double-blind, 6-week studies.
O'Donnell JB; Ekman EF; Spalding WM; Bhadra P; McCabe D; Berger MF
J Int Med Res; 2009; 37(6):1789-802. PubMed ID: 20146877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
